EULAR recommendations for the management of Behçet disease
Gülen Hatemi(Center for Rheumatology), Hasan Yazıcı(Istanbul University), Alan J. Silman(Nuffield Orthopaedic Centre), Carlo Salvarani(Sorbonne Université), Nicole Stübiger(Unknown), Sebahattin Yurdakul(Istanbul University), Ina Kötter(Eppendorf (Germany)), Ignazio Olivieri(Ospedale Madonna Delle Grazie), Aksel Sıva(Koç University), Miles Stanford(Imperial College Healthcare NHS Trust), Dongsik Bang(Catholic Kwandong University International St. Mary's Hospital), Bahram Bodaghi(Sorbonne Université), M.H. Houman(Hôpital La Rabta), Ahmet Gül(Istanbul University), Anne Chamberlain(University of Leeds), Petros P. Sfikakis(National and Kapodistrian University of Athens)
Cited by 721
Related Papers
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
|Osteoporosis International|2007|1.2k
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
|Annals of the Rheumatic Diseases|2006|798
2018 update of the EULAR recommendations for the management of Behçet's syndrome
|Annals of the Rheumatic Diseases|2018|771
The Long-Term Mortality and Morbidity of Behçet Syndrome
|Medicine|2003|757
EULAR evidence-based recommendations for the management of fibromyalgia syndrome
|Annals of the Rheumatic Diseases|2007|751